BioCentury | Mar 12, 2020
Product Development

Targeted degradation gets another bump with Kymera’s $102M raise

...undisclosed existing investors in the round. Kymera Therapeutics Inc. also received a strategic investment from The Leukemia & Lymphoma Society’s...
BioCentury | Jun 10, 2019
Politics & Policy

Stakeholders back Medicare Part D out-of-pocket cap, call for additional changes to lower patient costs

...Part D plans taking over the liability. PhRMA, BIO, several biopharma companies, patient groups including the Leukemia & Lymphoma Society...
...than requiring patients to spend thousands of dollars before becoming eligible for lower cost drugs. The Leukemia & Lymphoma Society...
BioCentury | May 10, 2019
Product Development

The time is now: novel partnerships and funding models for accelerating science to the marketplace

...the development of therapeutics for their constituents, as well as generate returns. And in 2016 The Leukemia & Lymphoma Society...
...Washington, D.C. Cystic Fibrosis Foundation, Bethesda, Md. Global Impact Investing Network (GIIN), New York, N.Y. The Leukemia & Lymphoma Society...
BioCentury | Apr 26, 2019
Product Development

For patients’ sake, collaborate already

...BioCentury. Companies and Institutions Mentioned Friends of Cancer Research, Washington, D.C. Kraft Accelerator, Boston, Mass. Leukemia & Lymphoma Society...
BioCentury | Apr 20, 2018
Finance

Refilling Alexion’s cupboard

...to treat advanced solid tumors that has been terminated. It is still being studied in The Leukemia & Lymphoma Society’s...
...Inc. (NASDAQ:BIIB), Cambridge, Mass. Blueprint Medicines Corp. (NASDAQ:BPMC), Cambridge, Mass. GNS Healthcare Inc., Cambridge, Mass. The Leukemia & Lymphoma Society...
...Corp. argenx S.E. Biogen Inc. Blueprint Medicines Corp. GNS Healthcare Inc. Moderna Therapeutics Inc. Neurovance Inc. Novelion Therapeutics Inc. Otsuka Pharmaceutical Co. Ltd. Sema4 Shire plc The Leukemia & Lymphoma Society Valeant...
BioCentury | Feb 10, 2018
Politics, Policy & Law

Money in your pocket

...winning formula wouldn’t be revealed, it would be impossible to determine the precise rebate amount. The Leukemia & Lymphoma Society...
...of Economic Advisors, Washington, D.C. Duke University, Durham, N.C. Inovalon Holdings Inc. (NASDAQ:INOV), Bowie, Md. The Leukemia & Lymphoma Society...
BioCentury | May 5, 2017
Politics, Policy & Law

Beyond right to try

...Alliance for Aging Research, American Cancer Society Cancer Action Network, Friends of Cancer Research , The Leukemia & Lymphoma Society...
...Friends of Cancer Research, Washington, D.C. Goldwater Institute, Phoenix, Ariz. Kids v. Cancer, Washington, D.C. The Leukemia & Lymphoma Society...
BioCentury | Dec 13, 2016
Distillery Therapeutics

Cancer

...S.A. markets Ridaura, an oral formulation of gold salt, to treat rheumatoid arthritis. Nestle and The Leukemia & Lymphoma Society...
BioCentury | Dec 10, 2016
Product Development

AML advances

...including midostaurin, enasidenib and Vyxeos liposomal cytarabine/daunorubicin from Jazz Pharmaceuticals plc . The clinicians and the Leukemia & Lymphoma Society...
...said there are also preclinical studies under way to test glasdegib with other targeted agents. The Leukemia & Lymphoma Society’s...
...Dublin, Ireland Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Karyopharm Therapeutics Inc. (NASDAQ:KPTI), Natick, Mass. The Leukemia & Lymphoma Society...
BioCentury | Oct 24, 2016
Clinical News

Leukemia & Lymphoma Society pipeline update

...The Leukemia & Lymphoma Society launched the collaborative Phase IIa/IIb Beat AML trial, which will evaluate multiple candidates to...
...some of the trial’s costs. Beat AML is expected to start enrolling patients by December. Leukemia & Lymphoma Society...
Items per page:
1 - 10 of 71
BioCentury | Mar 12, 2020
Product Development

Targeted degradation gets another bump with Kymera’s $102M raise

...undisclosed existing investors in the round. Kymera Therapeutics Inc. also received a strategic investment from The Leukemia & Lymphoma Society’s...
BioCentury | Jun 10, 2019
Politics & Policy

Stakeholders back Medicare Part D out-of-pocket cap, call for additional changes to lower patient costs

...Part D plans taking over the liability. PhRMA, BIO, several biopharma companies, patient groups including the Leukemia & Lymphoma Society...
...than requiring patients to spend thousands of dollars before becoming eligible for lower cost drugs. The Leukemia & Lymphoma Society...
BioCentury | May 10, 2019
Product Development

The time is now: novel partnerships and funding models for accelerating science to the marketplace

...the development of therapeutics for their constituents, as well as generate returns. And in 2016 The Leukemia & Lymphoma Society...
...Washington, D.C. Cystic Fibrosis Foundation, Bethesda, Md. Global Impact Investing Network (GIIN), New York, N.Y. The Leukemia & Lymphoma Society...
BioCentury | Apr 26, 2019
Product Development

For patients’ sake, collaborate already

...BioCentury. Companies and Institutions Mentioned Friends of Cancer Research, Washington, D.C. Kraft Accelerator, Boston, Mass. Leukemia & Lymphoma Society...
BioCentury | Apr 20, 2018
Finance

Refilling Alexion’s cupboard

...to treat advanced solid tumors that has been terminated. It is still being studied in The Leukemia & Lymphoma Society’s...
...Inc. (NASDAQ:BIIB), Cambridge, Mass. Blueprint Medicines Corp. (NASDAQ:BPMC), Cambridge, Mass. GNS Healthcare Inc., Cambridge, Mass. The Leukemia & Lymphoma Society...
...Corp. argenx S.E. Biogen Inc. Blueprint Medicines Corp. GNS Healthcare Inc. Moderna Therapeutics Inc. Neurovance Inc. Novelion Therapeutics Inc. Otsuka Pharmaceutical Co. Ltd. Sema4 Shire plc The Leukemia & Lymphoma Society Valeant...
BioCentury | Feb 10, 2018
Politics, Policy & Law

Money in your pocket

...winning formula wouldn’t be revealed, it would be impossible to determine the precise rebate amount. The Leukemia & Lymphoma Society...
...of Economic Advisors, Washington, D.C. Duke University, Durham, N.C. Inovalon Holdings Inc. (NASDAQ:INOV), Bowie, Md. The Leukemia & Lymphoma Society...
BioCentury | May 5, 2017
Politics, Policy & Law

Beyond right to try

...Alliance for Aging Research, American Cancer Society Cancer Action Network, Friends of Cancer Research , The Leukemia & Lymphoma Society...
...Friends of Cancer Research, Washington, D.C. Goldwater Institute, Phoenix, Ariz. Kids v. Cancer, Washington, D.C. The Leukemia & Lymphoma Society...
BioCentury | Dec 13, 2016
Distillery Therapeutics

Cancer

...S.A. markets Ridaura, an oral formulation of gold salt, to treat rheumatoid arthritis. Nestle and The Leukemia & Lymphoma Society...
BioCentury | Dec 10, 2016
Product Development

AML advances

...including midostaurin, enasidenib and Vyxeos liposomal cytarabine/daunorubicin from Jazz Pharmaceuticals plc . The clinicians and the Leukemia & Lymphoma Society...
...said there are also preclinical studies under way to test glasdegib with other targeted agents. The Leukemia & Lymphoma Society’s...
...Dublin, Ireland Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Karyopharm Therapeutics Inc. (NASDAQ:KPTI), Natick, Mass. The Leukemia & Lymphoma Society...
BioCentury | Oct 24, 2016
Clinical News

Leukemia & Lymphoma Society pipeline update

...The Leukemia & Lymphoma Society launched the collaborative Phase IIa/IIb Beat AML trial, which will evaluate multiple candidates to...
...some of the trial’s costs. Beat AML is expected to start enrolling patients by December. Leukemia & Lymphoma Society...
Items per page:
1 - 10 of 71